Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Current Assets: 2023-2024

Historic Current Assets for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $132.8 million.

  • Compass Therapeutics' Current Assets rose 56.67% to $221.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.1 million, marking a year-over-year increase of 56.67%. This contributed to the annual value of $132.8 million for FY2024, which is 13.73% down from last year.
  • According to the latest figures from FY2024, Compass Therapeutics' Current Assets is $132.8 million, which was down 13.73% from $153.9 million recorded in FY2023.
  • Over the past 5 years, Compass Therapeutics' Current Assets peaked at $153.9 million during FY2023, and registered a low of $132.8 million during FY2024.
  • Over the past 2 years, Compass Therapeutics' median Current Assets value was $143.3 million (recorded in 2023), while the average stood at $143.3 million.
  • Data for Compass Therapeutics' Current Assets shows a maximum YoY declined of 13.73% (in 2024) over the last 5 years.
  • Compass Therapeutics' Current Assets (Yearly) stood at $153.9 million in 2023, then dropped by 13.73% to $132.8 million in 2024.